Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients

British Journal of Cancer

Volumn 86, Issue 6, 2002, Pages 858-863

  Jager R ^a   List, B ^a   Knabbe, C ^b   Souttou, B ^d   Raulais, D ^e   Zeiler, T ^a   Wellstein, A ^c   Aigner, A ^a   Neubauer, A ^a   Zugmaier, G ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c GEORGETOWN UNIVERSITY   (United States)

^d Institut d'Oncologie Cellulaire et Moleculaire Humaine   (France)

^e INSERM   (France)

Author keywords

NSCLC; Pleiotrophin; SCLC; VEGF

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR; PLEIOTROPHIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CELL MIGRATION; DRUG BLOOD LEVEL; ENDOTHELIUM CELL; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; WOUND HEALING;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARRIER PROTEINS; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18344389157     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600202     Document Type: Article

References (24)

1. HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function
2. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients
3. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
4. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis
5. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo
6. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
7. Pleiotrophin stimulates fibroblasts, endothelial and epithelial cells, and is expressed in human cancer
8. Structural and functional characterization of full-length heparin-binding growth associated molecule
9. Serum midkine levels are increased in patients with various types of carcinomas
10. Differential expression and biological activity of the heparin-binding growth associated molecule (HB-GAM) in lung cancer cell lines
11. Circulating angiogenesis regulators in cancer patients
12. Cloning and expression of a development regulated protein that induces mitogenic and neurite outgrowth activity
13. Molecular cloning of the 18 kDa growth-associated protein of developing brain
14. Expression of midkine and pleiotropin in ovarian tumors
15. Angiogenic factors as tumor markers
16. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
17. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer
18. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
19. Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors
20. Pleiotrophin induces angiogenesis: Involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways
21. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer
22. Cellular distribution of the new growth factor (HB-GAM) mRNA in developing and adult rat tissues
23. A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine
24. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors